| Name | Title | Contact Details |
|---|---|---|
Martha Bell |
Director of Human Resources | Profile |
Actelion Pharmaceuticals is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in South San Francisco, CA. To find more information about Actelion Pharmaceuticals, please visit www.actelion.com
Storandt Pann Margolis is a La Grange, IL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Le`Fant is a Service Disabled, Veteran Owned Small Business that is Veteran Administration-certified. Our sole purpose is to enhance the ability of Federal Agencies to provide support to and care for Service Members, Veterans, and their families and caregivers.
Heron Therapeutics` Inc. (formerly A.P. Pharma` Inc.) is a specialty pharmaceutical company developing products using its proprietary Biochronomer™ polymer-based drug delivery platform. This drug delivery platform is designed to improve the therapeutic profile of injectable pharmaceuticals by converting them from products that must be injected once or twice per day to products that need to be injected only once every one or two weeks.
scPharmaceuticals, based in Lexington, MA, is a privately held biopharmaceutical company developing a portfolio of transformative pharmaceutical products for subcutaneous delivery. Based on widely used generic drugs that currently require intravenous or intramuscular injections, our innovative products will be administered subcutaneously via a proprietary patch pump. This avoids material risks and costs associated with the current delivery options. Our lead products are the first subcutaneous formulations of furosemide (the most widely used parenteral diuretic in treating heart failure) and ceftriaxone (the most widely used parenteral antibiotic outside the hospital setting). Our novel furosemide formulation enables convenient anytime anywhere use, for example in an outpatient setting instead of the emergency room or other in-patient settings. For ceftriaxone and other antibiotics, subcutaneous administration eliminates the need for PICCs (peripherally inserted central catheters), which are associated with serious complications, frequent adverse events and high medical cost. For further information on how we are transforming the administration of parenteral drugs.